Private equity targeting €1.2bn Mediq

Netherlands-based medicalised homecare provider and pharmaceutical distributor Mediq is for sale, with a potential €1.2bn price tag. With non-binding bids for the pan-European group due in the first week of November, HBI hears that a private equity buyer is almost certain with little interest from strategic parties.

Another Chinese hospital IPO in Hong Kong but market looks flat

Chinese private hospital operator Guodan Healthcare has refiled plans to IPO on the Hong Kong exchange and, if successful, will become the twelfth Chinese hospital in the country to list. But it's a crowded space and most of the 11 other stocks have underperformed in the last four years as our infographic shows.

IDH sale could lead to group breakup

UK-based NHS dental specialist IDH, which operates over 600 UK-based clinics as {my}dentist and supplies thousands of dentists with products and equipment through dental supplier DD, is for sale. Could the group could be broken up if the buyer for the whole is not found?

Indicative offers due in Mentaal Beter sale

Following on from our exclusive story last month confirming Dutch mental health provider Mentaal Beter is for sale, HBI hears there has been considerable interest in the deal.

ICG indirectly acquiring stake in €3bn nuclear medicine group

Intermediate Capital Group (ICG) is indirectly acquiring over 25% of the shares of Europe's largest radiopharmaceuticals provider Curium Pharma, HBI can reveal, after owner Capvest earlier pulled a majority sales process because of COVID-19.

UBS, EQT, TPG and Icade discuss COVID investment climate

Valuations in the healthcare services sector will roughly stay the same post-COVID, according to a panel of investors from UBS, EQT, Icade Sante and TPG at a HBI-365 panel. That's despite the fact that HBI-365 delegates do not think that deal flow will return to pre-pandemic levels until the second half of next year.

Cinven hires banks for Synlab 2021 IPO

HBI hears Synlab's private equity owner Cinven has mandated banks for an initial public offering, expected to take place next year. It will value Synlab at €5bn-6bn.

Scandinavian social care specialist buys big in Finland

eQ Care special investment fund has signed an agreement to sell a substantial portfolio of healthcare properties, predominantly elderly and special care homes, to a Scandinavian property fund with a focus on social care.

Find Us